NEUROBO PHARMACEUTICALS INC - COM NEW (NRBO)

CUSIP: 64132R206

Q4 2022 13F Holders as of 31 Dec 2022

Share change
+1,377,375
SEC-reported price per share
$0.72
Number of holders
16
Value change
+$840,968
Number of buys
15
Number of sells
2

Security key

64132R206

Report period

Q4 2022

Institutions

16

Top holders

10

Ownership snapshot

Top reported holders of NRBO - NEUROBO PHARMACEUTICALS INC - COM NEW (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
E&Investment, Inc.
Disclosed value leader
E&Investment, Inc.
Comparable rows
0/9
Latest evidence
16 Nov 2022
3/4/5 13F Highest disclosed value: $18,832,174 9 rows are not safely comparable across share classes. Showing 1-6 of 9 holder rows.

Quick read

E&Investment, Inc. has the largest disclosed position value at $18.83M.

0 of 9 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens E&Investment, Inc.'s linked filing trail.
Disclosed position value Top 5
E&Investment, Inc. $18.83M
GOLDMAN SACHS GROUP INC $3.82M
VANGUARD GROUP INC $156K
UBS Group AG $52K
BlackRock Finance, Inc. $9K

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 9 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
E&Investment, Inc.
3/4/5
10%+ Owner
—
denominator unverified
$18,832,174
6,016,669 shares
— 26 Jul 2022
GOLDMAN SACHS GROUP INC
3/4/5
10%+ Owner
—
denominator unverified
$3,820,171
1,220,502 shares
— 16 Nov 2022
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$156,000
11,393 shares
— 30 Sep 2022
UBS Group AG
13F
Company
13F
—
denominator unverified
$52,000
3,765 shares
— 30 Sep 2022
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$9,000
686 shares
— 30 Sep 2022
Tower Research Capital LLC (TRC)
13F
Company
13F
—
denominator unverified
$2,000
178 shares
— 30 Sep 2022
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2022

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
16
Shares
1,393,397
Rows available
16
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
5
Q4 2022 holders
16
Holder diff
11
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 value Q4 2022 value Value change Value Chg %
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .